These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Changes in glomerular hemodynamic response to angiotensin II after subacute renal denervation in rats. Tucker BJ; Mundy CA; Maciejewski AR; Printz MP; Ziegler MG; Pelayo JC; Blantz RC J Clin Invest; 1986 Sep; 78(3):680-8. PubMed ID: 3745432 [TBL] [Abstract][Full Text] [Related]
27. In vivo effects of angiotensin II on vascular smooth muscle contraction and blood pressure are mediated through a protein tyrosine-kinase-dependent mechanism. Sauro MD; Sudakow R; Burns S J Pharmacol Exp Ther; 1996 Jun; 277(3):1744-50. PubMed ID: 8667246 [TBL] [Abstract][Full Text] [Related]
28. Caffeine enhances the slow-pressor response to angiotensin II in rats. Evidence for a caffeine-angiotensin II interaction with the sympathetic nervous system. Ohnishi A; Li P; Branch RA; Holycross B; Jackson EK J Clin Invest; 1987 Jul; 80(1):13-6. PubMed ID: 3110209 [TBL] [Abstract][Full Text] [Related]
29. Are angiotensin receptors in vascular smooth muscles a homogeneous population? Tabrizchi R; Pang CC Eur J Pharmacol; 1987 Oct; 142(3):359-66. PubMed ID: 3428350 [TBL] [Abstract][Full Text] [Related]
30. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2). Wong PC; Hart SD; Zaspel AM; Chiu AT; Ardecky RJ; Smith RD; Timmermans PB J Pharmacol Exp Ther; 1990 Nov; 255(2):584-92. PubMed ID: 2243344 [TBL] [Abstract][Full Text] [Related]
31. Antihypertensive mechanism of captopril in renal hypertensive rats: studies with a nonpeptide angiotensin II receptor antagonist and an angiotensin II monoclonal antibody. Wong PC; Price WA; Reilly TM; Duncia JV; Timmermans PB J Pharmacol Exp Ther; 1989 Aug; 250(2):515-22. PubMed ID: 2668502 [TBL] [Abstract][Full Text] [Related]
32. (Des-Asp1) angiotensin I: a study of its pressor and steroidogenic activities in conscious rats. Campbell WB; Schmitz JM; Itskovitz HD Endocrinology; 1977 Jan; 100(1):46-51. PubMed ID: 187407 [TBL] [Abstract][Full Text] [Related]
33. Vascular angiotensin II receptors in renal and DOCA-salt hypertensive rats. Schiffrin EL; Thomé FS; Genest J Hypertension; 1983; 5(6 Pt 3):V16-21. PubMed ID: 6317555 [TBL] [Abstract][Full Text] [Related]
34. Difference between intracarotid and intravenous infusions of angiotensin II on baroreflex sensitivity and vasopressin release in conscious rats. Fenoy FJ; Ubeda M; García-Estañ J; Quesada T Rev Esp Fisiol; 1987 Sep; 43(3):355-60. PubMed ID: 3423394 [TBL] [Abstract][Full Text] [Related]
35. Pharmacology of SC-52458, an orally active, nonpeptide angiotensin AT1 receptor antagonist. Olins GM; Corpus VM; Chen ST; McMahon EG; Palomo MA; McGraw DE; Smits GJ; Null CL; Brown MA; Bittner SE J Cardiovasc Pharmacol; 1993 Oct; 22(4):617-25. PubMed ID: 7505365 [TBL] [Abstract][Full Text] [Related]
36. Pressor resistance to vasopressin in sodium depletion, potassium depletion, and cirrhosis. Murray BM; Paller MS Am J Physiol; 1986 Sep; 251(3 Pt 2):R525-30. PubMed ID: 2875660 [TBL] [Abstract][Full Text] [Related]
37. Mechanism of angiotensin I converting enzyme inhibition by SQ20,881 (less than Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro) in vivo. Further evidence for extrapulmonary conversion. Oparil S; Koerner T; O'Donoghue JK Hypertension; 1979; 1(1):13-22. PubMed ID: 232489 [TBL] [Abstract][Full Text] [Related]
38. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats. Wright JW; Roberts KA; Cook VI; Murray CE; Sardinia MF; Harding JW Brain Res; 1990 Apr; 514(1):5-10. PubMed ID: 2357530 [TBL] [Abstract][Full Text] [Related]
39. Diminished pressor response to exogenous norepinephrine and angiotensin II in septic, unanesthetized rats: evidence for a prostaglandin-mediated effect. Fink MP; Homer LD; Fletcher JR J Surg Res; 1985 Apr; 38(4):335-42. PubMed ID: 3889500 [TBL] [Abstract][Full Text] [Related]
40. Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist. Wong PC; Hart SD; Chiu AT; Herblin WF; Carini DJ; Smith RD; Wexler RR; Timmermans PB J Pharmacol Exp Ther; 1991 Nov; 259(2):861-70. PubMed ID: 1941632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]